Cellular and humoral immune responses to SARS-CoV-2 vaccination in patients after CD19.CAR T-cell therapy.
Reimann H, Kremer AN, Blumenberg V, Schmidt K, Aigner M, Jacobs B, Eisenhauer N, Kämpf A, Rösler W, Kharboutli S, Mougiakakos D, Lang V, Lischer C, Irrgang P, Leppkes M, Gonzalez JV, Krönke G, Kremer AE, Tenbusch M, Bruns H, Harrer T, Müller F, Schett G, Mackensen A, Subklewe M, Völkl S.
Reimann H, et al. Among authors: harrer t.
Blood Adv. 2023 May 23;7(10):2066-2069. doi: 10.1182/bloodadvances.2022007806.
Blood Adv. 2023.
PMID: 36206194
Free PMC article.
No abstract available.